GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (OTCPK:INRLF) » Definitions » PE Ratio

INRLF (Valneva SE) PE Ratio : At Loss (As of Dec. 12, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Valneva SE PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-12), Valneva SE's share price is $2.104. Valneva SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.07. Therefore, Valneva SE's PE Ratio for today is At Loss.

During the past 13 years, Valneva SE's highest PE Ratio was 322.00. The lowest was 0.00. And the median was 58.92.

Valneva SE's EPS (Diluted) for the three months ended in Sep. 2024 was $-0.08. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.07.

As of today (2024-12-12), Valneva SE's share price is $2.104. Valneva SE's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.12. Therefore, Valneva SE's PE Ratio without NRI ratio for today is At Loss.

During the past 13 years, Valneva SE's highest PE Ratio without NRI was 322.00. The lowest was 0.00. And the median was 63.20.

Valneva SE's EPS without NRI for the three months ended in Sep. 2024 was $-0.10. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.12.

During the past 3 years, the average EPS without NRI Growth Rate was -2.00% per year.

During the past 13 years, Valneva SE's highest 3-Year average EPS without NRI Growth Rate was 95.20% per year. The lowest was -251.80% per year. And the median was -2.45% per year.

Valneva SE's EPS (Basic) for the three months ended in Sep. 2024 was $-0.08. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.06.

Back to Basics: PE Ratio


Valneva SE PE Ratio Historical Data

The historical data trend for Valneva SE's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE PE Ratio Chart

Valneva SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Valneva SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison of Valneva SE's PE Ratio

For the Biotechnology subindustry, Valneva SE's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valneva SE's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's PE Ratio distribution charts can be found below:

* The bar in red indicates where Valneva SE's PE Ratio falls into.



Valneva SE PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Valneva SE's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=2.104/-0.066
=-31.88(At Loss)

Valneva SE's Share Price of today is $2.104.
Valneva SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Valneva SE  (OTCPK:INRLF) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Valneva SE PE Ratio Related Terms

Thank you for viewing the detailed overview of Valneva SE's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Valneva SE Business Description

Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

Valneva SE Headlines

From GuruFocus

Q1 2022 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q3 2022 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Full Year 2021 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q3 2020 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q3 2024 Valneva SE Earnings Call Transcript

By GuruFocus News 11-08-2024

Half Year 2023 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Nine Months 2019 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Full Year 2020 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Valneva SE - Special Call Transcript

By GuruFocus Research 02-09-2024